Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CAPR Capricor Therapeutics	$6.88 -3.9%	$10.29	$3.52 ▼ $23.40	$327.05M	0.82	2.11 million shs	2.09 million shs
INNV InnovAge	$3.93 -7.1%	$4.01	$2.60 ▼ $6.69	$571.10M	0.51	50,717 shs	50,654 shs
PDSB PDS Biotechnology	$1.15 -4.2%	$1.45	$0.85 ▼ $4.32	$54.85M	1.21	476,197 shs	289,150 shs
SNNA Sienna Biopharmaceuticals	$0.14	$0.14	$0.06 ▼ $3.80	$4.20M	2.67	1.87 million shs	13.32 million shs
WCUI Wellness Center Usa	$0.00	$0.00	$0.00 ▼ $0.00	$10K	4.89	3,325 shs	65,499 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CAPR Capricor Therapeutics	-1.10%	-37.19%	-41.26%	-36.36%	+48.55%
INNV InnovAge	-3.20%	+0.71%	+13.10%	+53.82%	-29.26%
PDSB PDS Biotechnology	-0.83%	-7.69%	-25.93%	+11.11%	-70.07%
SNNA Sienna Biopharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
WCUI Wellness Center Usa	0.00%	0.00%	-81.82%	0.00%	-87.50%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CAPR Capricor Therapeutics	2.5647 of 5 stars	4.6	1.0	0.0	0.0	1.5	0.8	0.6
INNV InnovAge	1.5278 of 5 stars	2.8	2.0	0.0	0.0	1.6	1.7	0.6
PDSB PDS Biotechnology	1.1778 of 5 stars	3.7	1.0	0.0	0.0	1.2	0.0	0.0
SNNA Sienna Biopharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
WCUI Wellness Center Usa	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CAPR Capricor Therapeutics	3.11	Buy	$22.56	227.84% Upside
INNV InnovAge	1.50	Reduce	$5.00	27.23% Upside
PDSB PDS Biotechnology	3.33	Buy	$9.00	682.61% Upside
SNNA Sienna Biopharmaceuticals	0.00	N/A	N/A	N/A
WCUI Wellness Center Usa	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest PDSB, INNV, SNNA, CAPR, and WCUI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/14/2025	CAPR Capricor Therapeutics	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/14/2025	CAPR Capricor Therapeutics	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$31.00 ➝ $12.00
7/11/2025	CAPR Capricor Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$20.00
7/11/2025	CAPR Capricor Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$77.00 ➝ $24.00
7/1/2025	PDSB PDS Biotechnology	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$13.00
6/30/2025	CAPR Capricor Therapeutics	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$20.00
6/26/2025	CAPR Capricor Therapeutics	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$21.00
6/25/2025	CAPR Capricor Therapeutics	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/25/2025	CAPR Capricor Therapeutics	Jones Trading Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$40.00 ➝ $29.00
6/24/2025	CAPR Capricor Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$77.00
6/23/2025	CAPR Capricor Therapeutics	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$43.00 ➝ $22.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CAPR Capricor Therapeutics	$22.27M	14.11	N/A	N/A	$3.20 per share	2.15
INNV InnovAge	$763.85M	0.69	N/A	N/A	$2.04 per share	1.93
PDSB PDS Biotechnology	N/A	N/A	N/A	N/A	$0.51 per share	N/A
SNNA Sienna Biopharmaceuticals	N/A	N/A	N/A	N/A	$1.27 per share	N/A
WCUI Wellness Center Usa	$660K	0.02	N/A	N/A	N/A	∞

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CAPR Capricor Therapeutics	-$40.47M	-$1.42	0.00	N/A	N/A	-181.71%	-62.42%	-48.36%	8/6/2025 (Estimated)
INNV InnovAge	-$21.34M	-$0.23	0.00	65.50	N/A	-3.75%	-11.91%	-5.85%	9/9/2025 (Estimated)
PDSB PDS Biotechnology	-$37.61M	-$0.94	0.00	N/A	N/A	N/A	-150.59%	-69.15%	8/12/2025 (Estimated)
SNNA Sienna Biopharmaceuticals	-$73.47M	-$3.59	N/A	N/A	N/A	N/A	-177.36%	-52.22%	N/A
WCUI Wellness Center Usa	-$750K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest PDSB, INNV, SNNA, CAPR, and WCUI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	PDSB PDS Biotechnology	-$0.24	N/A	N/A	N/A	N/A	N/A
8/6/2025	Q2 2025	CAPR Capricor Therapeutics	-$0.48	N/A	N/A	N/A	$2.60 million	N/A
5/14/2025	Q1 2025	PDSB PDS Biotechnology	-$0.25	-$0.21	+$0.04	-$0.21	N/A	N/A
5/13/2025	Q1 2025	CAPR Capricor Therapeutics	-$0.33	-$0.53	-$0.20	-$0.53	$3.16 million	$2.73 million
5/6/2025	Q3 2025	INNV InnovAge	-$0.02	-$0.08	-$0.06	-$0.08	$214.09 million	$218.14 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CAPR Capricor Therapeutics	N/A	N/A	N/A	N/A	N/A
INNV InnovAge	N/A	N/A	N/A	N/A	N/A
PDSB PDS Biotechnology	N/A	N/A	N/A	N/A	N/A
SNNA Sienna Biopharmaceuticals	N/A	N/A	N/A	N/A	N/A
WCUI Wellness Center Usa	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CAPR Capricor Therapeutics	N/A	6.55	6.55
INNV InnovAge	0.04	0.78	0.78
PDSB PDS Biotechnology	0.29	2.33	2.33
SNNA Sienna Biopharmaceuticals	N/A	15.27	15.27
WCUI Wellness Center Usa	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CAPR Capricor Therapeutics	21.68%
INNV InnovAge	12.26%
PDSB PDS Biotechnology	26.84%
SNNA Sienna Biopharmaceuticals	17.36%
WCUI Wellness Center Usa	0.01%

Insider Ownership

Company	Insider Ownership
CAPR Capricor Therapeutics	10.50%
INNV InnovAge	1.40%
PDSB PDS Biotechnology	9.20%
SNNA Sienna Biopharmaceuticals	27.20%
WCUI Wellness Center Usa	15.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CAPR Capricor Therapeutics	101	45.68 million	40.88 million	Optionable
INNV InnovAge	2,350	135.01 million	133.12 million	Optionable
PDSB PDS Biotechnology	20	45.71 million	41.51 million	Optionable
SNNA Sienna Biopharmaceuticals	39	30.91 million	N/A	Not Optionable
WCUI Wellness Center Usa	8	143.19 million	120.71 million	Not Optionable

PDSB, INNV, SNNA, CAPR, and WCUI Headlines

Recent News About These Companies

Healing begins where taboos end at SIU Pelvic Wellness Center

July 16 at 5:34 PM | nprillinois.orgN

Ragin Wellness Center offering trauma therapy to young people in Sumter

July 16 at 5:34 PM | abccolumbia.comA

5 walkouts of mentally ill patients prompt policy reform at Guam Behavioral Health and Wellness Center

July 13, 2025 | guampdn.comG

Forty Fort Parks and Recreation Committee donates to Cancer Wellness Center of NEPA

July 13, 2025 | timesleader.comT

Lamar Mental Wellness Center in Augusta aids mental health needs

July 11, 2025 | msn.com

Flagler Schools cut ribbon on new Wellness Center

July 9, 2025 | observerlocalnews.comO

West Monroe Honors Local Businesses with “Yard of the Month” Award for Outstanding Beautification to The Wellness Center

July 5, 2025 | msn.com

Avas Wellness Center and Spa to Anchor a Growing Wellness-Driven Ecosystem in Alibaug

July 2, 2025 | devdiscourse.comD

Erie Cancer Wellness Center Free Outdoor Summer Wellness Series July 10

July 1, 2025 | erienewsnow.comE

‘Shocked’: North Portland Wellness Center scorched by 3-alarm fire

June 10, 2025 | msn.com

Wildcat Wellness Center set to close in July for summer break

June 4, 2025 | msn.com

Senior wellness expo draws increased attendance at YMCA Wellness Center

May 21, 2025 | msn.com

LumiClinics Behavioral Wellness Center Revolutionizes Mental Health Care with Integrated Approach

May 17, 2025 | news.marketersmedia.comN

Cancer Wellness Center of NEPA holds Annual Walk

May 12, 2025 | timesleader.comT

Cancer Wellness Center gears up for major walk fundraiser

May 7, 2025 | msn.com

Wellness Center attendance up

April 16, 2025 | sdsucollegian.comS

MCCTC Plans New Health and Wellness Center

April 11, 2025 | businessjournaldaily.comB

Regional Wellness Center project planning on pause amid funding uncertainty

April 11, 2025 | duboiscountyfreepress.comD

Victorville’s Wellness Center receives major funding from San Bernardino County

April 11, 2025 | msn.com

USD To Host Wellness Center Natatorium Grand Opening And Ribbon Cutting

April 11, 2025 | plaintalk.netP

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDSB, INNV, SNNA, CAPR, and WCUI Company Descriptions

Capricor Therapeutics NASDAQ:CAPR

$6.88 -0.28 (-3.91%)

Closing price 04:00 PM Eastern

Extended Trading

$6.91 +0.03 (+0.44%)

As of 07:59 PM Eastern

Capricor Therapeutics, Inc. (NASDAQ:CAPR) is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy. Capricor has also established itself as one of the leading companies investigating the field of extracellular vesicles and is exploring the potential of CAP-2003, a cell-free, exosome-based candidate, to treat a variety of disorders.

InnovAge NASDAQ:INNV

$3.93 -0.30 (-7.09%)

Closing price 04:00 PM Eastern

Extended Trading

$3.93 0.00 (0.00%)

As of 04:10 PM Eastern

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.

PDS Biotechnology NASDAQ:PDSB

$1.15 -0.05 (-4.17%)

Closing price 04:00 PM Eastern

Extended Trading

$1.14 0.00 (-0.43%)

As of 06:49 PM Eastern

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, and human papillomavirus associated malignancies. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein (TARP) for treating prostate and breast cancers; and PDS0103 for ovarian, colorectal, lung, and breast cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment; and PDS0104, a novel investigational Tyrosinase-related Protein 2 targeted immunotherapy that stimulates a potent targeted T cell attack against melanoma. Further, the company provides PDS0202, a novel investigational influenza vaccine that generates broad and robust antibody and T cell responses that provide protection against continually evolving strains of seasonal flu and potentially emerging pandemic flu. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. The company was founded in 2005 and is based in Princeton, New Jersey.

Sienna Biopharmaceuticals NASDAQ:SNNA

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Wellness Center Usa OTCMKTS:WCUI

$0.0001 0.00 (0.00%)

As of 07/17/2025 01:00 PM Eastern

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time